[ad_1]
The “Sputnik V” vaccine, the Russian alternative to Western vaccines, will be many times cheaper than those made by Pfizer and Moderna and can be transported starting in February in temperatures between 2 and 8 degrees Celsius, he said. , on Monday, at the EFE agency, Kiril Dmitriev, the head of the state fund (Russian Fund for Direct Investments – FIDR) in charge of selling and distributing the vaccine.
He did not specify what the price of the vaccine would be, promising to announce it this week. He recalled that the effectiveness of the Russian vaccine is 92%, according to preliminary data from the third phase clinical trials, writes agerpres.ro.
Read also: Government blockade! Violeta Alexandru would have isolated herself with the stamp of the ministry! Official addresses lie on the desks
This vaccine will be delivered to other countries in December or January and will also be produced in countries such as Brazil, India, China, and South Korea.
Regarding the transport of the vaccine, which in Pfizer’s case requires a temperature of -70 degrees, and in the case of Moderna it is -20 degrees, Kiril Dmitriev said that the first batches of the Sputnik V vaccine can be stored at -18 degrees, and from February the freeze-drying technology will be used, used to dehydrate the vaccine, which will facilitate its transport.
Read also: News for all students in Romania! When the schools could reopen
“Starting in February, we will supply most of the doses at a temperature between 2 and 8 degrees. This will reduce transport restrictions,” the Russian official said. He added that Russia’s goal is not that Sputnik V is the only vaccine on the market, but that it is part of a series of vaccines that will be distributed around the world, because “only together, by joining forces, can we win. “. coronavirus’.
Kiril Dmitriev also said that the demand for the Sputnik V vaccine is around one billion people and that Russia’s production capacity for the whole of next year will reach about half of that demand.
Read also: Bomb-revelation! Minister Cîțu is in debt to the bank of which he was chief economist! There is a huge amount in between
But the Russian COVID-19 vaccine is viewed with skepticism in many countries, mainly because it was registered in Russia prior to the completion of clinical trials, and because its preliminary results have not been evaluated by independent researchers and have not been published in scientific journals. .
.
[ad_2]
Source link
